Eosinophil chemotactic factor. Release from human polymorphonuclear neutrophils by arachidonic acid

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Eosinophil chemotactic factors (ECFs) play a crucial role in inflammatory responses.
• The precise mechanisms regulating ECF release and their cellular sources are not fully understood.

Purpose of the Study:

• To investigate the role of arachidonic acid (AA) in the release of ECF from human polymorphonuclear neutrophils.
• To characterize the properties and specificity of the AA-induced ECF.

Main Methods:

• Incubation of human polymorphonuclear neutrophils with various arachidonic acid derivatives.
• Dose-response studies to assess ECF release.
• Kinetic analysis of ECF secretion.
• Gel filtration and subcellular fractionation to analyze ECF properties.

Main Results:

• Arachidonic acid (AA), specifically its methyl ester, induced a dose-dependent, non-cytotoxic release of ECF from human polymorphonuclear neutrophils.
• The released ECF demonstrated high specificity for eosinophils, without attracting neutrophils.
• ECF release was observed from rat basophil leukemia cells but not from human lymphocytes.
• Kinetic studies showed rapid ECF release with early peak and subsequent decline.
• ECF release was influenced by pH, temperature, and incubation medium.

Conclusions:

• Arachidonic acid (AA) is a potent inducer of eosinophil chemotactic factor (ECF) release from human neutrophils.
• The AA-induced ECF is a distinct biological activity, potentially a conversion product of AA, with potent chemoattractant effects on eosinophils.
• AA-mediated ECF release represents a significant mechanism in cellular activation and inflammatory processes.